Skip to main content

Allergy and Infectious Diseases Research in Colorado

CFDA 93.855 — federal program obligations to Colorado

Total obligated

$493.0M

Awards

353

USAspending.gov records $475,768,789.60 in Allergy And Infectious Diseases Research obligations (CFDA 93.855) with place of performance in Colorado, across 339 awards. Three hundred thirty-nine instruments against $475.77 million imply about $1.40 million per award. This page joins NIAID catalog 93.855 to the CO geography tag. It is not a CDC investigation cell, not a lab census, and not cash already paid. Obligations are not outlays.

Key figures

  • CFDA 93.855 shows $475,768,789.60 in Colorado obligations on 339 awards.
  • The mean is about $1.40 million per award.
  • The catalog is NIAID 93.855, not CDC investigations.
  • Colorado is a place-of-performance tag, not a lab or PI census.
  • Figures are obligations, not outlays.

Colorado crossed with CFDA 93.855

CFDA 93.855 is titled ALLERGY AND INFECTIOUS DISEASES RESEARCH. Crossed with Colorado place of performance, obligations sum to $475,768,789.60 on 339 awards. The national 93.855 hub includes other states. Colorado’s spending hub includes other programs. Only this intersection is reported here. $475,768,789.60 is an obligation aggregate from USAspending.gov, not an outlay and not a count of labs in Denver or Boulder.

Three hundred thirty-nine awards is a multi-project extramural pattern: NIAID assistance often posts as hundreds of discrete records rather than one statewide block. The join does not name recipients. Packet facts are $475,768,789.60, 339 awards, CO, and 93.855. Correlation is not causation. FEC donations do not fund this USAspending cell. Keep NIAID research and Colorado together when reading $475,768,789.60.

93.855 is not a CDC investigation catalog in Colorado

CDC investigation catalogs use different CFDA numbers. Mixing those series into $475,768,789.60 would invent a broader total than this cell contains. Facts available: Colorado, CFDA 93.855, $475,768,789.60, 339 awards. Study titles, activity codes, and publication counts are unpublished.

The catalog title names allergy and infectious diseases research, not a ranking of academic medical centers. Dividing $475,768,789.60 by 339 yields about $1.40 million per award. Unique recipients are unpublished. 339 is not a lab or PI census.

Full analysis: Allergy and infectious diseases research in Colorado

Questions

How much NIAID research is obligated in Colorado?
USAspending records $475,768,789.60 in CFDA 93.855 obligations with Colorado place of performance on 339 awards. That is the pair total, not an outlay. Keep Allergy And Infectious Diseases Research and Colorado together when citing $475,768,789.60.
Does 339 awards mean 339 Colorado laboratories?
339 is a USAspending award-record count, not a lab or PI census. The implied mean is about $1.40 million per award. Unique recipients are unpublished. 339 is a record count, not a person or facility census.
Is this Colorado’s total federal research spending?
No. This join is CFDA 93.855 only. Other NIH institute catalogs appear on separate Colorado program pages. Nationwide 93.855 is not limited to Colorado. Obligations of $475,768,789.60 are not outlays. The overlay is the live NIAID research–Colorado table.
Do these obligations equal research completed?
No. $475,768,789.60 is an obligation sum. Outlays are a different USAspending series. Drawdowns can lag the federal obligation. This packet has no outlay total. Original filings remain on USAspending.gov for this 93.855 × CO pair.

USAspending.gov CFDA program aggregates by place of performance state. Obligations are not outlays.

How this pair fits

All data ties →

Explore related views: National Allergy and Infectious Diseases Research profile · All programs in Colorado · All spending in Colorado